HF
EUCRU

HRT Financial’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

HRT Financial’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,385
Closed -$114K – 3584
2022
Q3 		$114K Hold
11,385
– – ﹤0.01% 2366
2022
Q2 		$114K Hold
11,385
– – ﹤0.01% 2403
2022
Q1 		$112K Hold
11,385
– – ﹤0.01% 2632
2021
Q4 		$113K Hold
11,385
– – ﹤0.01% 2727
2021
Q3 		$113K Hold
11,385
– – ﹤0.01% 2865
2021
Q2 		$116K Hold
11,385
– – ﹤0.01% 2559
2021
Q1 		$115K Hold
11,385
– – ﹤0.01% 2441
2020
Q4 		$121K Buy
+11,385
New +$116K ﹤0.01% 1607

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return